Mylan NV (MYL)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1500 CORPORATE DRIVE CANONSBURG, PA 15317

Mylan is engaged in the development, licensing, manufacture, marketing and distribution of generic and branded generic pharmaceuticals, pharmaceuticals line and active pharmaceutical ingredients. Co. has two reportable segments: Generics, which develops, manufactures, sells, and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as active pharmaceutical ingredients: and Specialty, which manufactures and sales branded specialty nebulized and injectable products. The Generics segment also focuses on developing active pharmaceutical ingredients with non-infringing processes.

Data based on most recent fiscal year report
Market Cap11.174 Billion Shares Outstanding516.13 Million Avg Volume8.725 Million
1-Yr BETA vs S&P TR1.935 Current Ratio1.39 Quick Ratio0.83
View SEC Filings from MYL instead.

View recent insider trading info

Funds Holding MYL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MYL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHEEHAN JOHN D SENIOR VICE PRESIDENT, CFO

  • Officer
220,395 2020-01-14 0

DIMICK NEIL F

  • Director
0 2020-01-02 1

HIGGINS MELINA E

  • Director
0 2019-12-31 2

BORKOWSKI EDWARD

392,806 2019-12-20 0

MARK RICHARD A

  • Director
14,627 2019-12-10 3

MAROON JOSEPH C MD

  • Director
715,116 2019-12-05 0

VOLLEBREGT SJOERD S

  • Director
42,258 2019-08-13 2

COURY ROBERT J

  • Director
1,383,587 2019-08-02 3

CAMPBELL PAUL SEE REMARKS

  • Officer
25,731 2019-08-01 4

PARRISH MARK W

  • Director
58,991 2019-05-14 1

GALLAGHER DANIEL MARTIN JR CHIEF LEGAL OFFICER

  • Officer
17,041 2019-04-01 2

VANDERVEEN RANDALL L

  • Director
44,206 2019-03-01 1

MAURO ANTHONY CHIEF COMMERCIAL OFFICER

  • Officer
101,704 2019-03-01 3

KORMAN HARRY

  • Director
22,934 2019-03-01 1

MALIK RAJIV PRESIDENT

  • Officer
  • Director
496,925 2019-03-01 3

CINDRICH ROBERT J

  • Director
21,468 2019-03-01 1

LYONS DILLON JOELLEN

  • Director
12,028 2019-03-01 1

PARKS KENNETH SCOTT CHIEF FINANCIAL OFFICER

  • Officer
15,108 2019-03-01 3

VAN DER MEER MOHR PAULINE

  • Director
2,684 2019-03-01 1

BRESCH HEATHER M CHIEF EXECUTIVE OFFICER

BRESCH HEATHER M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
618,230 2019-03-01 3

BRESCH HEATHER M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
856,417 2019-02-19 3

CAMERON WENDY

  • Director
No longer subject to file 2018-06-29 0

PIATT RODNEY L

  • Director
No longer subject to file 2017-06-22 0

LEECH DOUGLAS J

  • Director
No longer subject to file 2017-06-22 0

ABBOTT LABORATORIES

ABBOTT PRODUCTS

ABBOTT INVESTMENTS LUXEMBOURG S.A R.L.

  • 10% Owner
No longer subject to file 2017-03-23 0

ABBOTT PRODUCTS

  • 10% Owner
62,782,018 2015-07-28 0

ABBOTT LABORATORIES

ABBOTT ESTABLISHED PRODUCTS HOLDINGS GIBRALTAR LTD

ABBOTT INVESTMENTS LUXEMBOURG S.A R.L.

  • 10% Owner
69,750,000 2015-04-07 0

ABBOTT LABORATORIES

LABORATOIRES FOURNIER S.A.S.

ABBOTT ESTABLISHED PRODUCTS HOLDINGS GIBRALTAR LTD

ABBOTT INVESTMENTS LUXEMBOURG S.A R.L.

  • 10% Owner
75,000,000 2015-03-31 0

TODD C B

  • Director
229,636 2014-03-14 0

RIZZO DANIEL C JR SVP, CORP CONTROLLER & CAO

  • Officer
83,140 2014-03-06 0

PUSKAR MIKE

  • Director
263,171 2009-12-17 0

VARNEY JOLENE L. CHIEF FINANCIAL OFFICER

  • Officer
0 2009-06-08 0

NIMMAGADDA PRASAD

  • Director
1,205,308 2009-04-25 0

WILLIAMS STUART A SPECIAL COUNSEL, OFFICE OF CEO

  • Officer
110,433 2008-03-07 0

MYERS CAROLYN J PRESIDENT, DEY L.P.

  • Officer
8,507 2008-02-14 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments